HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Huang Selected Research

2- (4- morpholinoanilino)- 6- cyclohexylaminopurine

1/2020Reversine and herbal Xiang-Sha-Liu-Jun-Zi decoction ameliorate thioacetamide-induced hepatic injury by regulating the RelA/NF-κB/caspase signaling pathway.
1/2019Relation of AURKB over-expression to low survival rate in BCRA and reversine-modulated aurora B kinase in breast cancer cell lines.
12/2016Effect of reversine on cell cycle, apoptosis, and activation of hepatic stellate cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Huang Research Topics

Disease

133Neoplasms (Cancer)
10/2022 - 01/2003
43Infections
07/2022 - 11/2004
39Hypertension (High Blood Pressure)
01/2022 - 04/2005
36Inflammation (Inflammations)
06/2022 - 01/2008
26Neoplasm Metastasis (Metastasis)
01/2022 - 01/2010
23Hepatocellular Carcinoma (Hepatoma)
04/2022 - 07/2005
21Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 04/2005
19Atherosclerosis
01/2022 - 08/2005
19Fibrosis (Cirrhosis)
01/2022 - 04/2010
17Hypoxia (Hypoxemia)
01/2022 - 11/2004
13Carcinogenesis
10/2022 - 02/2003
13Obesity
03/2022 - 11/2011
13Breast Neoplasms (Breast Cancer)
02/2021 - 10/2008
12Wounds and Injuries (Trauma)
09/2022 - 04/2016
11Bacterial Infections (Bacterial Infection)
04/2022 - 04/2019
11Myocardial Infarction
01/2022 - 09/2009
11Insulin Resistance
01/2022 - 07/2010
11Carcinoma (Carcinomatosis)
11/2021 - 02/2003
10Atherosclerotic Plaque (Atheroma)
01/2022 - 04/2008
9Virus Diseases (Viral Diseases)
07/2022 - 04/2016
9Necrosis
12/2021 - 01/2008
8Hyperglycemia
06/2022 - 06/2009
8Stroke (Strokes)
03/2022 - 02/2011
8Osteoporosis
01/2022 - 08/2008
8Body Weight (Weight, Body)
11/2021 - 04/2005
8Lung Neoplasms (Lung Cancer)
09/2021 - 04/2002
8Heart Failure
12/2020 - 03/2006
8Vascular Diseases (Vascular Disease)
01/2020 - 01/2012
7Allergic Rhinitis
04/2022 - 01/2015
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 06/2013
7Metabolic Diseases (Metabolic Disease)
01/2022 - 01/2010
7Tuberculosis (Tuberculoses)
11/2021 - 04/2012
7Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2019
7Reperfusion Injury
01/2020 - 03/2003
7Hypercholesterolemia
01/2018 - 07/2009
6Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 09/2012
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 05/2011
6Liver Neoplasms (Liver Cancer)
10/2021 - 12/2008
6Adenocarcinoma of Lung
06/2021 - 03/2014
6Ischemia
01/2021 - 02/2011
5COVID-19
12/2022 - 12/2020
5Diabetes Mellitus
06/2022 - 03/2006
5Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2013
5Coronary Disease (Coronary Heart Disease)
01/2022 - 05/2007
5Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2017
5Heart Diseases (Heart Disease)
01/2022 - 08/2007
5Stomach Neoplasms (Stomach Cancer)
01/2022 - 07/2018
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2009
5Rheumatoid Arthritis
10/2021 - 01/2015
5Hypersensitivity (Allergy)
07/2021 - 02/2012

Drug/Important Bio-Agent (IBA)

62Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2004
32Pharmaceutical PreparationsIBA
01/2022 - 11/2008
24CytokinesIBA
12/2022 - 01/2008
23Biological ProductsIBA
10/2022 - 04/2005
23Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2010
14MicroRNAs (MicroRNA)IBA
06/2022 - 12/2010
14Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022 - 03/2006
12Therapeutic UsesIBA
01/2022 - 09/2009
12Messenger RNA (mRNA)IBA
09/2021 - 06/2003
12LipidsIBA
01/2021 - 08/2005
11CholesterolIBA
03/2022 - 04/2005
11Small Interfering RNA (siRNA)IBA
01/2022 - 03/2014
11AntioxidantsIBA
11/2020 - 01/2008
10DNA (Deoxyribonucleic Acid)IBA
12/2022 - 01/2006
10Glucose (Dextrose)FDA LinkGeneric
07/2021 - 07/2008
9EnzymesIBA
10/2021 - 01/2008
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2021 - 11/2004
9Angiotensin IIIBA
01/2021 - 01/2009
9Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017 - 05/2008
8Transcription Factors (Transcription Factor)IBA
01/2022 - 06/2011
8Long Noncoding RNAIBA
11/2021 - 12/2017
8Interleukin-6 (Interleukin 6)IBA
01/2021 - 08/2014
7AntigensIBA
01/2022 - 10/2008
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 02/2017
7Phosphotransferases (Kinase)IBA
01/2022 - 07/2011
7RNA (Ribonucleic Acid)IBA
01/2022 - 01/2020
7VaccinesIBA
01/2021 - 03/2017
7CollagenIBA
01/2021 - 04/2010
7Peptides (Polypeptides)IBA
04/2019 - 05/2012
6LigandsIBA
01/2022 - 07/2014
6AcidsIBA
01/2022 - 01/2009
6Oxygen (Dioxygen)IBA
07/2021 - 01/2014
6Hormones (Hormone)IBA
01/2021 - 02/2003
6AdiponectinIBA
01/2020 - 11/2010
5AlbuminsIBA
04/2022 - 11/2017
5Polysaccharides (Glycans)IBA
02/2022 - 01/2011
5CalciumIBA
01/2022 - 01/2008
5Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2022 - 12/2012
5Mechanistic Target of Rapamycin Complex 1IBA
01/2022 - 10/2013
5GoldIBA
10/2021 - 09/2012
5Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2021 - 01/2010
5Protein Kinases (Protein Kinase)IBA
01/2021 - 06/2009
5Drug CarriersIBA
11/2020 - 06/2014

Therapy/Procedure

55Therapeutics
07/2022 - 12/2008
27Drug Therapy (Chemotherapy)
01/2022 - 12/2009
10Radiotherapy
01/2022 - 12/2009
5Immunotherapy
12/2022 - 07/2005
5Transcranial Direct Current Stimulation
07/2022 - 07/2013
5Aftercare (After-Treatment)
01/2022 - 01/2005
5Intravenous Injections
11/2021 - 01/2017